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ABSTRACT
International Journal of Exercise Science 13(4): 1382-1401, 2020. This study assessed validity and
reliability of the VO2 Master Pro portable metabolic analyzer for assessment of oxygen consumption (VO2) and
minute ventilation (VE). In Protocol 1, eight male participants (height: 182.6 ± 5.8 cm, weight: 79.6 ± 8.3 kg, age: 41.0
± 12.3 years) with previous competitive cycling experience completed an hour-long stationary cycling protocol
twice, progressing from 100-300 Watts every 10 minutes while wearing the VO2 Master and a criterion measure
(Parvomedics) for five minutes each, at each stage. In Protocol 2, 16 recreationally active male participants (height:
168.2 ± 8.4 cm, weight: 76.5 ± 13.3 kg, age: 23.0 ± 9.4 years) completed three incremental, maximal stationary cycling
tests wearing one of three analyzers for each test (VO2 Master version 1.1.1, VO2 Master version 1.2.1, Parvomedics).
For Protocol 1 and convergent validity, the VO2 Master had mean absolute differences from the Parvomedics of
<0.3 L/min for absolute VO2 and <5 L/min for VE overall and at each exercise stage. Mean absolute percent
differences (MAPD) for VO2 and VE were <9% overall and <12% at each stage. Test-retest reliability of the VO2
Master (MAPD: 8.9-10.9%) was somewhat poorer than the Parvomedics (MAPD: 5.3-7.6%). For Protocol 2, validity
was similar for both VO2 Master models (MAPD ~12% overall) compared to the Parvomedics for VO2 and VE. The
VO2 Master had an acceptable validity and test-retest reliability for most intensities tested and may be an appealing
option for field-based VO2 and VE analysis.

KEY WORDS: Metabolism, indirect calorimetry, VO2max, metabolic analysis, portable
metabolic analyzer
INTRODUCTION
Measurement of oxygen consumption (VO2) during rest and exercise in laboratory and field
settings is of fundamental importance for areas including general health, diagnosis of chronic
disease, exercise training, and athletic performance. Early automated metabolic systems were
not portable, limiting testing to either resting measures or measures that could be performed on
a stationary ergometer (e.g., treadmill, cycle) in a laboratory setting. However, since the late
1980’s several user-worn, portable systems capable of capturing VO2 have emerged, allowing
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for important metabolic and caloric expenditure analyses to be performed in field-based settings
(15).
Brands of portable analyzers including COSMED, Oxycon, and MetaMax have received
extensive validation and field use in a variety of settings, providing evidence of the importance
of capturing such field-based data (19, 24). However, their cost, which at $30,000-$50,000+ is
more than main brands of laboratory-based metabolic analyzers, may preclude their use in
fitness settings, by individual sports teams, and at smaller colleges/universities. These types of
organizations need a less costly option capable of performing high-quality metabolic analyses.
Full analysis of caloric expenditure and macronutrient fuel utilization requires measurement of
both VO2 and carbon dioxide consumption (VCO2) for determination of respiratory exchange
ratio (12). However, several handheld analyzers capable of measuring resting VO2 (but not
VCO2) are available at a fraction of the cost of fully equipped analyzers. Even without VCO2
measurement, such devices have been shown to provide more accurate measures of resting
caloric expenditure than popular equations such as the Harris-Benedict (9) or Mifflin St. Jeor (21)
equations (10, 27, 28). Accordingly, such devices may have utility for measuring resting caloric
expenditure and metabolic rate in weight-loss or hospital settings (10). However, these devices
are not designed to be able to assess energy expenditure during exercise and are, therefore,
unsuitable for performance testing in fitness or athletic realms.
A recently developed, portable metabolic analyzer, the VO2 Master Pro (VO2 Master Health
Sensors Inc., Vernon, British Columbia, CA), is reportedly capable of measuring VO2 (but not
VCO2) across a variety of intensities from rest to maximal exercise. At a cost of <$5,000
(https://vo2master.com/shop/) and with a size smaller than the major portable metabolic
analyzer brands, the VO2 Master Pro is an appealing option for VO2 and minute ventilation
assessment. According to the manufacturer, the VO2 Master Pro is accurate to ±3% O2 and ±3%
flow (ventilation) compared to a breathing simulator (17). However, we are not aware of
independent validations of the VO2 Master analyzer. With development of such technologies,
it is important for end-users to understand their validity and reliability. Therefore, the purpose
of this study was to assess validity and reliability (both test-retest and inter-device) of the VO2
Master metabolic analyzer in a laboratory setting.
METHODS
Protocol 1: Hour test protocol
Participants
Eight males with previous cycling experience (range 2-40 years, average 18.5 years) completed
what will hereafter be called the “hour test protocol.” This protocol design allowed for
assessment of VO2 Master validity and test-retest reliability. For this protocol, potential
participants were invited to complete the study if they were confident they could complete 10
minutes of cycling at 250 Watts (W), with the ideal participant able to complete 10 minutes at
300 W. Participants had to be between the ages of 18-80 years and able to safely participate in
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vigorous-intensity exercise. To ensure participant safety, participants completed a physical
activity readiness questionnaire (PAR-Q). Any potential participants with risks identified by the
PAR-Q were required to provide written physician approval for high-intensity exercise prior to
participation. This research was carried out fully in accordance to the ethical standards of the
International Journal of Exercise Science (22). Additionally, the college’s Institutional Review
Board approved all study protocols before testing began, and participants gave their written
informed consent prior to participation. Demographic data for the hour test protocol are
included in Table 1.
Table 1. Participant demographics for hour test protocol.
Age (years)
Height (cm)
Weight (kg)
Body mass index (kg/m2)
Data are shown as mean (standard deviation).

41.0 (12.3)
182.6 (5.8)
79.6 (8.3)
24.1 (2.0)

Protocol
Parvomedics analyzer: The Parvomedics TrueOne 2400 metabolic cart (Parvomedics, Inc., Salt
Lake City, UT, USA) was used as a comparative measure of VO2 and minute ventilation.
Previous research has shown the Parvomedics to accurately measure both VO2 and ventilation
across a range of intensities compared to the gold-standard Douglas bag method, rendering the
Parvomedics a suitable criterion measure for comparison in this study (1).
The Parvomedics was prepared using standard procedures, including a 30-minute warm-up
period prior to calibration. Gas calibration was completed first and according to manufacturer
settings. Ambient temperature, humidity, and barometric pressure were measured using a
FanJu weather station (FanJu Electronics Technology Company, Ltd., Fujian, China) and input
into the software, and gas calibration was completed with the machine sampling room air and
then a known gas mixture of 16% O2 and 4% CO2. The gas calibration was completed until
results were within ±1% for both CO2 and O2 with a total difference of ≤1%. Next, the flowmeter
calibration was completed using a 3 L flow syringe, using one detection stroke, four flush
strokes, and five calibration strokes at flow rates of 50-80 L/min, 100-199 L/min, 200-299 L/min,
300-399 L/min, and 400-599 L/min, as per manufacturer recommendations. The flowmeter
calibration was completed until the results were within ±1%. A Hans Rudolph (Hans Rudolph,
Inc., Shawnee, KS, USA) 2700B two-way non-rebreathing valve system was used, where all
inhaled air came from the ambient environment, and all exhaled air flowed through a tube into
the mixing chamber of the Parvomedics system. Participants were connected to the Hans
Rudolph valve via a mouthpiece, and noseclips were used to ensure all exhaled air was captured
by the system. A headgear setup (Model 2726; Hans Rudolph, Inc., Shawnee, KS, USA) held the
mouthpiece and valve in place. Total dead space in the mouthpiece/valve setup was ~93 ml.
The Parvomedics records breath-by-breath ventilation, VO2, and VCO2; however, VCO2 was not
used in the present study.
VO2 Master Pro analyzer: The VO2 Master Pro, version 1.1.1, was used for the hour test protocol.
The unit and mask weigh 0.32 kg, with power provided by a single AAA battery. The analyzer
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was connected to a Hans Rudolph 7450 V2, over-nose mask for wear using a mask adapter “user
piece” (a plastic tube that connects the analyzer and mask, with an exhaust hole for air entry
and exit), and a soft headgear was used to secure the unit to the participants’ faces. There are
two manufacturer-supplied user piece sizes, one that allows a flow rate of 30-160 L/min, and
one that allows for a flow rate of 40-220 L/min. For all trials in both protocols, the 30-160 L/min
user piece was used. A single-use filter was placed between the user piece and the analyzer, as
per manufacturer instructions, and replaced following each test. Total dead space in the
mask/user piece setup was ~125 ml.
The VO2 Master unit contains a passive, pump-less system for gas sampling, a galvanic fuel cell
O2 sensor, and a differential pressure flow sensor (personal communications with
manufacturer). The VO2 Master automatically calibrated to the ambient air for gas
concentrations, ambient temperature, humidity, and barometric pressure when it was turned on
(the device does not calibrate to other O2 concentrations). Following gas calibration, the VO2
Master was fitted to participants, and participants were instructed to take 10-15 deep breaths for
flowmeter calibration. Once the protocol was started, the device recalibrated automatically at 5
minutes and 25 minutes (took ~30-45 seconds each time). The device measures breath-by-breath
ventilation and VO2 but does not have a CO2 sensor and, therefore, cannot capture VCO2. The
VO2 Master transmitted data via Bluetooth to an iPod (Apple, Inc. Cupertino, CA, USA)
equipped with the VO2 Master mobile application for storage and later download.
Cycling equipment: A Monark Ergomedic Stationary 894E cycle (Monark Exercise, Vansbro,
Sweden) was used during the hour test protocol. This cycle does not need calibration as weights
are added to a 1kg basket to adjust pedaling resistance. Participants had the option to use the
standard pedals that came with the cycle or use their own (such as clipless pedals and shoes).
The 894E has resistance increments of 0.1 kg. Power output (in W) was calculated as W =
resistance (kg) * revolutions/min.
Other equipment: Participants wore a Polar H10 heart rate monitor (Polar Electro Oy, Kempele,
Finland) on the chest, just below the xiphoid process. The monitor transmitted real-time heart
rate data to a mobile phone (Samsung Galaxy S7; Samsung, Seoul, South Korea) equipped with
the Polar Beat (version 3.3.6) mobile application. Participant weight was taken at the beginning
of each visit, while wearing shoes and clothing to be worn during the cycling, using a Taylor
Precision Scale (Taylor USA, Entrada Del Con, New Mexico).
Cycling protocol: Participants (N=8) completed two separate hour test protocols, spaced at least
48 hours apart and performed as close to the same time of day as possible. For each test,
participants were asked to refrain from exercise for least 12 hours and caffeine/food for at least
3 hours prior to testing. Upon arrival, participants were fitted on the Monark 894E, attached
their own pedals if desired, and completed a short (~10 minute), self-directed warm-up to
ensure fit and comfort on the cycle. Following the warmup, the incremental test protocol started
at 100 W and increased by 50 W (100, 150, 200, 250, 300 W) every 10 minutes. At every stage,
participants wore the VO2 Master and the Parvomedics analyzer for five minutes each, with the
order of analyzer wear randomized for each workload and counterbalanced between visits to
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eliminate any potential ordering effects due to VO2 drift or the slow component of VO2. An
overview of the hour test protocol can be found in Table 2. Research staff managed the switching
of analyzers, which took ~45 seconds. While the analyzers were being switched, participants
had the option of maintaining pedaling cadence or resting. If participants continued pedaling,
the stage timer would continue; conversely, if they elected to stop pedaling during the switching
process, the stage timer would be stopped until the switch was completed and the participants
resumed the necessary pedaling cadence.
In the last ~30 seconds of wearing each analyzer at each stage (i.e., every 5 minutes), steady-state
heart rate and rating of perceived exertion (Borg 6-20 scale) were recorded (3). Participants were
allowed to choose their ideal cycling cadence (revolutions/min), and the resistance was adjusted
accordingly so that the participants could stay as close as possible to their ideal cadence at each
stage. For both visits, participants were required to use the same pedals and cadence/resistance
settings at each stage. If participants deviated from the required cadence by more than ±2
revolutions/minute, they received verbal reminders by the research staff. Toward the end of the
protocol, if participants could not maintain the necessary cadence after two consecutive
reminders by the research staff, the protocol was ended.
Due to the extended length of the hour test protocol, participants were allowed to listen to music
if they desired. Additionally, participants were given the option to have a box fan placed ~4
meters directly in front of them and set to the lowest setting. Pilot testing prior to the study
starting showed that the fan had no apparent effect on VO2 or ventilation for any fan speed
when used at a distance of 3 or more meters. If participants chose to use music and/or fan for
their first test, the same music/fan settings were used in the second test.
Table 2. Overview of the hour test protocol.
Time
Watts
Day 1 (N=8) analyzer#
Day 2 (N=8) analyzer
10-minute warm-up
Self-selected
None
None
0-5 minutes
100
Parvomedics
VO2 Master
5-10 minutes
100
VO2 Master
Parvomedics
10-15 minutes
150
VO2 Master
Parvomedics
15-20 minutes
150
Parvomedics
VO2 Master
20-25 minutes
200
Parvomedics
VO2 Master
25-30 minutes
200
VO2 Master
Parvomedics
30-35 minutes
250
VO2 Master
Parvomedics
35-40 minutes
250
Parvomedics
VO2 Master
40-45 minutes
300
Parvomedics
VO2 Master
45-50 minutes
300
VO2 Master
Parvomedics
#The order of analyzer wear was randomized and counterbalanced across participants. This table provides an
example protocol for one participant.

Statistical analysis
Since gas sampling did not occur simultaneously for the two analyzers (which would allow for
criterion validity assessment), we opted for assessing convergent validity by comparing outputs
from analyzers during the same activity intensities but sampled at different times. We were also
able to determine test-retest reliability for the VO2 Master analyzers using data from the hour
test protocol. For the reliability analysis, the Parvomedics data served as a comparison to better
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understand the extent to which the observed differences between analyzers were due to day-today variability in physiologic function vs. due to reliability of the devices.
Absolute VO2 (L/min) and minute ventilation (L/min) data from the Parvomedics and VO2
Master analyzers were reintegrated to 30-second intervals for analysis, and both heart rate and
RPE were measured at each stage to confirm equal physiologic and perceived workload when
wearing the different monitors. Fraction of expired oxygen consumption and relative VO2 data
were also collected but, for conciseness, are mentioned but not fully presented. Using G Power
(v 3.0.10), the minimum sample size needed to obtain a significant correlation of ≥0.80 with 80%
power is n=7, so both test protocols were adequately powered for determination of high
between-analyzer correlations.
To determine validity of the VO2 Master version 1.1.1, data from minutes 3-5 and 8-10 (the final
two minutes of each stage, for each analyzer), were averaged across both visits and compared
using paired-samples t-tests. Additionally, Pearson correlation coefficients were calculated
overall, and mean absolute differences and mean absolute percent differences were calculated
both overall and for each stage between the Parvomedics and VO2 Master version 1.1.1.
To determine test-retest (intra-device) reliability of the Parvomedics and VO2 Master version
1.1.1 analyzers, the final two minutes of data from each stage were first averaged for each
analyzer. Then, Pearson correlation coefficients were calculated overall, and mean absolute
differences and mean absolute percent differences were calculated overall and at each stage
between the first and second protocols for each analyzer. Additionally, coefficients of variation
were calculated for each analyzer and each outcome variable to determine stability in analyzer
output.
Mean absolute percent differences were arbitrarily considered acceptable when they were <10%,
in accordance with past work validating other field-based measurement tools (23). All statistical
analyses were conducted in SPSS version 24.0 (IBM Corp., Armonk, NY, USA). A p value of
p<0.05 paired t-tests analysis was used to denote statistical significance, and 0.05≤p≤0.10 was
used to denote non-significant trends.
Protocol 2: Maximal test protocol
Participants
Sixteen recreationally active males (with or without cycling experience) completed what will
hereafter be called the “maximal test protocol.” This protocol design also allowed for assessment
of VO2 Master validity as well as inter-monitor reliability. Demographic data for these
participants are in Table 3. Participants had to be between the ages of 18-80 years and able to
safely participate in vigorous-intensity exercise. To ensure participant safety, participants
completed a PAR-Q, and participants selecting “Yes” to any of the questions were required to
obtain written physician approval for high-intensity exercise prior to participation. This protocol
was also approved by the college’s Institutional Review Board approved and was carried out
fully in accordance to the ethical standards of the International Journal of Exercise Science (22).
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Table 3. Participant demographics for maximal test protocol.
Age (years)
Height (cm)
Weight (kg)
Body mass index (kg/m2)
Data are shown as mean (standard deviation).

23.1 (9.4)
168.0 (8.4)
76.5 (13.3)
25.4 (3.3)

Protocol
The Parvomedics TrueOne 2400 metabolic cart was used as a comparative measure of VO2 and
minute ventilation. Calibration of the Parvomedics and mouthpiece use were identical to the
hour test protocol. The VO2 Master Pro, versions 1.1.1 and 1.2.1, were used the maximal test
protocol. Device specifications and calibration are identical for versions 1.1.1 and 1.2.1, and the
calibration procedure was identical to that used in the hour test protocol.
A Monark Ergomedic Stationary 828E cycle (Monark Exercise, Vansbro, Sweden) was used for
the maximal test protocol. The cycle was calibrated for resistance before testing began using 0,
2, and 4 kg weights. The participants used the stock pedals that came with the cycle and adjusted
the standard pedal clips to match their foot size. The 828E has resistance increments of 0.5 kg.
Power output (in W) was calculated as W = resistance (kg) * revolutions/min.
Participants wore a chest-based Polar H10 heart rate monitor, which transmitted real-time heart
rate data to a mobile phone equipped with the Polar Beat application. Finally, participant weight
was assessed in the same way as for the hour test protocol.
Participants (N=16) completed two maximal exercise tests, spaced at least 48 hours apart and
performed as close to the same time of day as possible. For each test, participants were asked to
refrain from exercise for at least 12 hours and caffeine/food for at least 3 hours prior to testing.
When participants reported to the laboratory, they were fitted on the Monark 828E and
completed a short (~5 minute), self-directed warm-up. The maximal exercise tests started at 50
W and increased by 50 W increments every three minutes until exhaustion. An overview of the
maximal test protocol is in Table 4. With 30 seconds left in each stage, steady-state heart rate and
rating of perceived exertion (Borg 6-20 scale) were recorded. Participants were allowed to choose
their ideal cycling cadence (revolutions/min), and the resistance was adjusted accordingly so
that the participants could stay close to their ideal cadence at each stage. If participants did not
have an ideal cadence, the research staff helped them find a comfortable cadence. The same
cadence was used for each test. If participants deviated from the required cadence by more than
±2 revolutions/minute, they received verbal reminders by the research staff. Toward the end of
the protocol, if participants could not maintain the necessary cadence after two consecutive
reminders by the research staff, the protocol was ended. The maximal time and workload were
noted at the end of each test. For one maximal test, participants wore the Parvomedics, and for
the other test participants wore the VO2 Master (version 1.1.1); the order of wearing these
analyzers was randomized.
Near the end of data collection for the maximal test protocol, the VO2 Master version 1.2.1 was
released, and we were able to conduct a third maximal exercise test on 13 of the 16 participants
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with the newer version of the analyzer. Note that the test using the VO2 Master version 1.2.1
was the last test for all participants and, therefore, was not randomized for order as the first two
tests were. The inclusion of version 1.2.1 allowed inter-device reliability of the VO2 Master to be
determined.
Table 4. Overview of the maximal test protocol.
Time*
Watts
Day 1 (N=16) analyzer@ Day 2 (N=16) analyzer Day 3 (n=13) analyzer
5-minute warm-up Self-selected
None
None
None
0-3 minutes
50
Parvomedics
VO2 Master v1.1.1
VO2 Master v1.2.1
3-6 minutes
100
Parvomedics
VO2 Master v1.1.1
VO2 Master v1.2.1
6-9 minutes
150
Parvomedics
VO2 Master v1.1.1
VO2 Master v1.2.1
9-12 minutes
200
Parvomedics
VO2 Master v1.1.1
VO2 Master v1.2.1
12-15 minutes
250
Parvomedics
VO2 Master v1.1.1
VO2 Master v1.2.1
15-18 minutes
300
Parvomedics
VO2 Master v1.1.1
VO2 Master v1.2.1
18-21 minutes
350
Parvomedics
VO2 Master v1.1.1
VO2 Master v1.2.1
*Participants completed as many stages as possible, until exhaustion.
@The order of analyzer wear was randomized for the Parvomedics and VO2 Master v1.1.1, but all participants who
completed the VO2 Master v1.2.1 protocol did so after the other protocols.

Statistical analysis
As with the hour test protocol, we assessed convergent validity of the VO2 Master analyzers
with the Parvomedics. We were also able to determine inter-device reliability for the VO2 Master
analyzers using data from the maximal test protocol. Absolute VO2 (L/min) and minute
ventilation (L/min) data from the Parvomedics and VO2 Master analyzers were reintegrated to
30-second intervals for analysis, and both heart rate and RPE were measured at each stage to
confirm equal physiologic and perceived workload when wearing the different monitors. Data
from minutes 2-3 (the last minute) of each stage were taken as steady-state values. The minute
ventilation rates for >90% of the participants were <30 L/min during the 50 W stage, so data
were not captured by the VO2 Master. Thus, the lowest intensity at which we analyzed data was
100 W.
To determine convergent validity of the VO2 Master analyzers, data from the three analyzers
(Parvomedics, VO2 Master version 1.1.1, VO2 Master version 1.2.1) were compared using
repeated-measures analysis of variance (RMANOVA) with a false discovery rate correction for
multiple comparisons (7); a p value of p<0.05 was used to denote statistical significance, and
0.05≤p≤0.10 was used to denote non-significant trends. Additionally, Pearson correlation
coefficients were calculated overall, and mean absolute differences and mean absolute percent
differences were calculated between the Parvomedics and each VO2 Master analyzer both
overall and at each stage. Inter-device reliability of the VO2 Master analyzers was determined
by calculating Pearson correlation coefficients overall as well as mean absolute differences and
mean absolute percent differences overall and at each stage between the version 1.1.1 and 1.2.1
of VO2 Master analyzer.
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RESULTS
Hour test protocol: All eight participants were able to complete the 250 W stage in both hourlong tests, and five participants were able to complete the 300 W stage in both tests. Heart rate
and RPE data (not shown, available upon request) were <3% different between analyzers and
had between-analyzer correlations ≥0.99, suggesting no significant differences in physiologic
load when wearing each analyzer at a given stage. Compared to the Parvomedics, the VO2
Master non-significantly trended (0.05≤p≤0.10) toward underestimating VO2 at 100 and 150 W
and either significantly overestimated or non-significantly trended toward overestimating VO2
at the 250 and 300 W stages (Figure 1). Average absolute VO2 was <0.2 L/min different between
analyzers at all stages. Minute ventilation was significantly higher for the VO2 Master at 250 W
and non-significantly trended toward being higher at 150 W, compared to the Parvomedics
(Figure 2).

Figure 1. Parvomedics and VO2 Master (version 1.1.1) oxygen consumption measures during hour test protocol.
Error bars represent standard deviations.
*Indicates significant difference from Parvomedics analyzer (p<0.05).
^Indicates non-significant trend toward difference from Parvomedics analyzer (p=0.05-0.10).
N=8 for 100-250 W and n=5 for 300 W.
Parvomedics: Parvomedics TrueOne 2400 metabolic analyzer; VO2 Master: VO2 Master Pro version 1.1.1
metabolic analyzer; W: Watts.
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Figure 2. Parvomedics and VO2 Master (version 1.1.1) ventilation measures during hour test protocol.
Error bars represent standard deviations.
*Indicates significant difference from Parvomedics analyzer (p<0.05).
^Indicates non-significant trend toward difference from Parvomedics analyzer (p=0.05-0.10).
N=8 for 100-250 W and n=5 for 300 W.
Parvomedics: Parvomedics TrueOne 2400 metabolic analyzer; VO2 Master: VO2 Master Pro version 1.1.1 metabolic
analyzer; W: Watts.

Mean absolute and percent differences between analyzers are shown in Table 5, which allows
for assessment of convergent validity of the analyzers. At all stages, VO2 was within 0.3 L/min,
which translated to being <1 MET (3.5 ml/kg/min) different between analyzers, and in all cases
other than 100 W the mean absolute percent difference for VO2 and minute ventilation was
<10%, indicating acceptable accuracy.
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Table 5. Mean absolute differences, mean absolute percent differences, and between-analyzer correlations for
metabolic variables measured by the VO2 Master (version 1.1.1), compared to the Parvomedics, during the hour
test protocol.
VO2 (L/min)
VE (L/min)
Overall
MAD
0.21 (0.14)
4.9 (4.5)
MAPD (%)
8.2 (6.0)
7.3 (7.1)
Correlation
0.97
0.97
100 W
MAD
MAPD (%)

0.17 (0.12)
11.1 (7.9)

4.6 (4.9)
10.6 (10.6)

150 W
MAD
MAPD (%)

0.19 (0.11)
8.8 (5.4)

3.5 (3.3)
6.2 (5.7)

200 W
MAD
MAPD (%)

0.27 (0.19)
9.5 (6.1)

7.1 (6.2)
9.6 (8.0)

250 W
MAD
MAPD (%)

0.21 (0.19)
6.0 (5.4)

4.8 (4.3)
4.8 (3.9)

300 W
MAD
0.17 (0.06)
4.2 (2.3)
MAPD (%)
4.4 (1.6)
3.7 (1.8)
Data are shown as mean (standard deviation).
N=8 for 100-250 W and n=5 for 300 W.
MAD: mean absolute difference between analyzers; MAPD: mean absolute percent difference between analyzers;
W: Watts; VO2: oxygen consumption; VE: minute ventilation.

Comparisons of Day 1 testing to Day 2 testing are shown in Table 6 and allow for assessment of
test-retest reliability. Overall and in all stages, VO2 varied less between days for the Parvomedics
than the VO2 Master, indicating better test-retest reliability of the Parvomedics. Day-to-day
variability in ventilation data were not consistently different between analyzers. Mean absolute
percent differences were acceptable (<10%) for minute ventilation overall and at 150-300 W, but
were <10% at only 250 and 300 W for VO2. Overall and for 100-250 W, the Parvomedics had
lower coefficients of variation than the VO2 Master VO2, minute ventilation, indicating better
test-retest reliability of the Parvomedics. These were reversed at 300 W, with higher coefficients
of variation for the Parvomedics than the VO2 Master for VO2 and minute ventilation.
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Table 6. Mean absolute differences, mean absolute percent differences, and between-day correlations for metabolic
variables measured by the VO2 Master (version 1.1.1) and Parvomedics on Day 1 vs. Day 2, during the hour test
protocol.
VO2 Master
Parvomedics
VO2 (L/min)
VE (L/min)
VO2 (L/min)
VE (L/min)
Overall
MAD
0.26 (0.21)
5.8 (4.1)
0.14 (0.17)
5.5 (5.8)
MAPD (%)
10.9 (9.4)
8.9 (7.3)
5.3 (5.7)
7.6 (6.4)
Correlation
0.96
0.98
0.96
0.96
CV (%)
11.4
15.1
8.5
12.1
100 W
MAD
MAPD (%)
CV (%)

0.23 (0.20)
15.1 (12.0)
14.6

5.7 (4.2)
13.1 (10.0)
16.0

0.09 (0.08)
5.2 (5.1)
7.9

4.2 (3.2)
9.8 (6.3)
10.7

150 W
MAD
MAPD (%)
CV (%)

0.27 (0.21)
13.5 (11.4)
12.3

5.0 (3.9)
9.5 (8.2)
13.0

0.17 (0.23)
7.4 (8.8)
9.8

2.7 (2.2)
5.1 (4.2)
9.5

200 W
MAD
MAPD (%)
CV (%)

0.32 (0.23)
11.3 (8.3)
13.3

6.5 (4.3)
9.2 (6.2)
16.8

0.10 (0.07)
3.5 (2.5)
8.7

5.9 (7.6)
7.8 (9.0)
13.2

250 W
MAD
MAPD (%)
CV (%)

0.22 (0.20)
6.3 (6.0)
10.1

5.0 (4.2)
5.0 (3.9)
16.5

0.23 (0.26)
6.3 (6.4)
9.6

7.1 (6.5)
7.0 (5.8)
14.5

300 W
MAD
0.28 (0.23)
7.5 (4.7)
0.12 (0.09)
9.2 (7.7)
MAPD (%)
6.8 (5.6)
6.9 (5.0)
3.2 (2.6)
8.1 (6.9)
CV (%)
5.6
12.4
5.7
12.9
Data are shown as mean (standard deviation).
N=8 for 100-250 W and n=5 for 300 W.
MAD: mean absolute difference between analyzers; MAPD: mean absolute percent difference between analyzers;
CV: coefficient of variation; W: Watts; VO2: oxygen consumption; VE: minute ventilation.

Maximal test protocol: Heart rate and RPE were <5% different and had correlations ≥0.93 overall
across the three test conditions, suggesting similar physiologic load across visits for each stage.
Both VO2 Master analyzers had significantly lower absolute VO2 than the Parvomedics at 100
W, and the VO2 Master version 1.1.1 analyzer also had significantly lower VO2 than the
Parvomedics at 150 W (Figure 3). There were no differences in VO2 between VO2 Master
analyzers at any stage. Average absolute VO2 was <0.3 L/min different among the three devices
at the 100-250 W stages. The VO2 Master version 1.2.1 non-significantly trended toward higher
minute ventilation than the other two analyzers at 100 W only (Figure 4).
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Figure 3. Parvomedics and VO2 Master (versions 1.1.1 and 1.2.1) oxygen consumption measures during maximal
test protocol.
Error bars represent standard deviations. Note that 300 and 350 Watts do not have standard deviations, and
statistical tests were not performed, due to sample size of n=1.
n=13 for 100-200 Watts, n=7 for 250 Watts, and n=1 for 300-350 Watts.
*Indicates significant difference from Parvomedics analyzer only (p<0.05).
Parvomedics: Parvomedics TrueOne 2400; VO2 Master 1.1.1: VO2 Master analyzer version 1.1.1. VO2 Master 1.2.1:
VO2 Master analyzer version 1.2.1; W: Watts.
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Figure 4. Parvomedics and VO2 Master (versions 1.1.1 and 1.2.1) ventilation measures during maximal test
protocol.
Error bars represent standard deviations. Note that 300 and 350 Watts do not have standard deviations, and
statistical tests were not performed, due to sample size of n=1.
n=13 for 100-200 Watts, n=7 for 250 Watts, and n=1 for 300-350 Watts.
^Indicates non-significant trend toward difference from VO2 Master version 1.2.1 analyzer (p=0.05-0.10).
Parvomedics: Parvomedics TrueOne 2400; VO2 Master 1.1.1: VO2 Master analyzer version 1.1.1. VO2 Master 1.2.1:
VO2 Master analyzer version 1.2.1; W: Watts.

Overall and at each stage, absolute and percent differences in VO2 and ventilation were similar
when comparing each of the VO2 Master analyzers to the Parvomedics, indicating similar
convergent validity of the different VO2 Master versions (Table 7). In assessing inter-device
reliability, VO2 and minute ventilation were 13-14% different between analyzers, with no
apparent improvement in percent differences with increasing exercise intensity.
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Table 7. Mean absolute differences, mean absolute percent differences, and between-analyzer correlations for
metabolic variables measured by the Parvomedics and VO2 Master (versions 1.1.1 and 1.2.1) during the maximal
test protocol.
VO2 Master version 1.1.1
VO2 Master version 1.2.1
VO2 Master version 1.1.1
compared to Parvomedics
compared to Parvomedics
compared to version 1.2.1
VO2 (L/min)
VE (L/min)
VO2 (L/min)
VE (L/min)
VO2 (L/min)
VE (L/min)
Overall
MAD
0.27 (0.22)
6.9 (6.9)
0.26 (0.17)
6.8 (5.7)
0.32 (0.24)
8.7 (7.5)
MAPD (%)
12.0 (10.1)
10.3 (8.6)
11.9 (8.2)
10.3 (7.2)
14.0 (8.4)
13.2 (9.9)
Correlation
0.93
0.95
0.93
0.96
0.88
0.94
100 W
MAD
MAPD (%)

0.24 (0.17)
17.9 (12.5)

3.8 (3.5)
10.0 (8.5)

0.19 (0.14)
13.7 (10.4)

3.8 (2.4)
11.2 (7.8)

0.20 (0.13)
14.4 (9.4)

4.8 (3.3)
13.4 (8.9)

150 W
MAD
MAPD (%)

0.19 (0.17)
9.3 (8.8)

5.9 (5.0)
10.6 (9.2)

0.26 (0.14)
12.7 (7.4)

4.8 (4.0)
9.0 (8.3)

0.28 (0.15)
13.7 (7.0)

6.8 (5.3)
12.9 (11.2)

200 W
MAD
MAPD (%)

0.27 (0.26)
9.4 (8.5)

8.2 (6.3)
10.2 (7.3)

0.26 (0.19)
9.8 (7.7)

8.2 (4.6)
10.7 (6.3)

0.36 (0.22)
12.8 (7.3)

9.4 (6.3)
12.0 (9.1)

250 W
MAD
MAPD (%)

0.39 (0.30)
11.3 (8.6)

11.0 (11.4)
11.3 (12.2)

0.40 (0.22)
12.6 (7.5)

10.2 (8.4)
9.2 (7.3)

0.62 (0.37)
18.5 (10.3)

17.9 (11.3)
17.6 (12.3)

300 W#
MAD
MAPD (%)

0.27
7.4

2.0
1.7

0.29
8.0

13.7
12.4

0.02
0.6

15.7
14.1

350 W#
MAD
0.60
21.7
0.26
23.4
0.34
1.5
MAPD (%)
14.9
14.8
6.2
15.9
8.7
1.1
Data are shown as mean (standard deviation).
n=13 for 100-200 Watts, n=7 for 250 Watts, and n=1 for 300-350 Watts.
#300 and 350 Watts do not have standard deviations due to sample size of n=1.
MAD: mean absolute difference between analyzers; MAPD: mean absolute percent difference between analyzers;
W: Watts; VO2: oxygen consumption; VE: minute ventilation.

DISCUSSION
Technological advances in metabolic analysis equipment have allowed for new and innovative
ways to assess human health and athletic performance through measurement of VO2 and minute
ventilation and associated caloric expenditure during rest and exercise. In the case of the VO2
Master Pro, its portability and low cost have the potential to allow metabolic and caloric analyses
in populations and settings not previously accessible. However, new metabolic analysis
technologies must first be validated against existing, industry standards before being suitable
for widespread use. As such, our study assessed validity and reliability (both test-retest and
inter-device) of the VO2 Master, compared to the Parvomedics metabolic analyzer.
International Journal of Exercise Science

1396

http://www.intjexersci.com

Int J Exerc Sci 13(4): 1382-1401, 2020
Validity: Both protocols in our study generally indicated that the VO2 Master analyzers either
trended toward or had significantly lower VO2 than the Parvomedics at 100 and 150 W, whereas
there was either no difference or slight overestimation by the VO2 Master (hour test protocol
only) at 250 and 300 W. For version 1.1.1 of the VO2 Master, underestimation of VO2 at the lower
workloads was due to overestimation of the fraction of expired O2 measured by the O2 sensor
(data not shown), and this appears to be true in version 1.2.1 for 100 W in the maximal test
protocol as well. Despite differences reaching statistical significance at some stages, absolute
differences between analyzers in the hour test protocol were <0.3 L/min between analyzers
(translating to a difference in relative VO2 of <3.0 ml/kg/min), which amounted to roughly 8%
difference for both. Additionally, percent differences decreased as exercise intensity increased,
suggesting that the VO2 Master may be better suited for VO2 measures at vigorous or nearmaximal intensities. Absolute differences were higher in the maximal test protocol than the hour
test protocol, but we attribute this to the additional variability added by having tests on separate
days for the maximal test protocol. Notably, differences from the Parvomedics were less for the
VO2 Master version 1.2.1 vs. version 1.1.1 in the maximal protocol, suggesting that both versions
likely measure VO2 to within 1 MET (3.5 ml/kg/min) of Parvomedics measures across all tested
exercise intensities. Additionally, correlations between the VO2 Master and Parvomedics were
0.97 in the hour test protocol and 0.92-0.93 in the maximal test protocol, demonstrating strong
agreement between analyzer brands.
Minute ventilation data were (or trended toward being) significantly higher for the VO2 Master
version 1.1.1 than the Parvomedics for 150 and 250 W but not at 100, 200, or 300 W in the hour
test protocol. Similarly, minute ventilation was significantly higher for the VO2 Master version
1.2.1 compared to the other analyzers at 100 W during the maximal test protocol, but there were
no other differences among analyzers at any stage. Absolute differences averaged <5 L/min
(~7%) in the hour test protocol and <7 L/min (~10%) in the maximal test protocol, and
correlations were ≥0.95 for both protocols, again suggesting strong agreement between both
versions of VO2 Master with the Parvomedics.
To our knowledge, our study is the first to report validity data for the VO2 Master analyzer, so
it is not possible to directly compare our findings to past work with the VO2 Master. However,
comparisons to other metabolic analyzer brands is informative to provide indirect comparisons
of device error across brands. Importantly, previous studies validating major brands including
COSMED, Oxycon, and MetaMax indicate comparable degrees of error as the VO2 Master.
Kawakami et al. (11) found that the COSMED K2 had absolute VO2 measures 0.1-0.2 L/min
different than a criterion during submaximal exercise, and McLaughlin et al. (18) found that the
COSMED K4b2 significantly overestimated absolute VO2 by ~0.1 L/min at cycling workloads of
50-200W. In both studies, the authors advocated that these differences are of little practical
significance. Other studies validating the COSMED have found little or no difference from
criterion measures for VO2 measurement (13, 14). Additionally, a study by Rosdahl et al. (26)
validating the Oxycon Mobile have found slight overestimation of VO2 during submaximal
exercise but an underestimation of absolute VO2 by ~0.2 L/min. Finally, the MetaMax 3B has
been validated by several groups, generally finding that the MetaMax slightly overestimates
absolute VO2 compared to a criterion, by up to ~0.3 L/min, during submaximal and maximal
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exercise (4, 16, 30). The similar magnitudes of differences found with other analyzer brands in
these previous studies to those found with the VO2 Master, coupled with the popularity of these
other analyzer brands, suggest that the differences in VO2 found between the VO2 Master and
Parvomedics in our study may be of little practical significance.
Reliability: Our study addressed test-retest reliability for the Parvomedics and VO2 Master
(v1.1.1) across testing days in the hour test protocol. Mean absolute differences, mean absolute
percent differences, and coefficients of variation for VO2 and minute ventilation were
consistently lower between days for the Parvomedics compared to the VO2 Master, indicating
better test-retest reliability of the Parvomedics. Differences were also above 10% for VO2 at 100200 W and minute ventilation at 100-150 W but not at the highest intensities, signifying that
reliability is better for higher or near-maximal intensities than lower intensities. Correlations for
all variables were ≥0.96 for the VO2 Master and Parvomedics, indicating strong between-day
agreement for both analyzers.
As with the validity data, we are unaware of past studies examining reliability of the VO2 Master
and, therefore, focus our discussion on comparison to other portable analyzer brands. Past work
with the COSMED K2 and K4b2 found coefficients of variation of ~3-13% for VO2 and minute
ventilation variables during submaximal and maximal exercise (13, 14, 29), and these are slightly
better than the 11.4-15.1% found in our study. However, the correlations in this study (r≥0.94)
compare favorably to past work, with studies reporting correlations of 0.70-0.96 for metabolic
variables assessed with various COSMED models (5, 6, 14, 29). Past studies assessing test-retest
reliability for the Oxycon (coefficients of variation 2.8-5.8%) (26) and MetaMax (coefficients of
variation 5.5-7.6%, correlations of r=0.77-0.99) (2, 20, 25) are similar to that of the COSMED.
Together, these findings suggest that the VO2 Master has slightly higher variability in monitor
output but equally strong between-day agreement as compared to other major portable analyzer
brands.
Data on inter-monitor reliability of portable metabolic analyzers are sparse. One study by
Guidetti et al. (8) with the COSMED K5 found mean absolute errors of <1% and correlations of
r>0.99 when evaluating inter-unit reliability using a metabolic simulator. These numbers are
similar to the metabolic simulator data comparison reported by the manufacturer of VO2 Master
(17). Notably, data produced by a metabolic simulator under carefully controlled conditions
represents the best possible scenario for analyzer performance, so it would be expected that
reliability of the COSMED would be lower in field settings or when tested on humans, as was
found in our study for the VO2 Master.
Aside from little past research examining inter-device reliability of portable metabolic analyzers,
we are cautious to make firm conclusions regarding inter-device reliability from our analysis.
The maximal test protocols took place on different days, introducing the confounding variable
of inter-day variability of metabolism. While randomization of visit order would eliminate some
of the potential bias, visits were not randomized between VO2 Master versions 1.1.1 and 1.2.1
because version 1.2.1 did not become available for purchase until testing with version 1.1.1 was
nearly complete. We elected to include these data, even though imperfect, to gain preliminary
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insights into inter-device reliability. However, further testing, perhaps with a protocol similar
to our hour test protocol, would yield better data for determination of inter-device reliability.
Study strengths and limitations: This study had several notable strengths. First, our study
assessed both validity and reliability using two different testing protocols and in different
populations, which gives a better indication of how the VO2 Master device functions in a variety
of populations and intensities. Heart rate and RPE data were included to confirm similar
physiologic workloads across tests, and the counterbalanced design within each stage (hour test
protocol) eliminated potential effects of VO2 drift or the slow component of VO2. Finally, a fan
was placed in front of participants in the hour test protocol but was not used in the maximal test
protocol; use of the fan did not lower analyzer validity or reliability, providing preliminary
evidence that the device functionality is not impacted by moderate headwind.
Several study limitations must also be acknowledged. Our sample size, while comparable to
past validation studies, was small and consisted entirely of male participants. Validation across
a larger, more diverse population is warranted. The lack of randomization for the VO2 Master
version 1.2.1 in the maximal test protocol is another limitation, which precludes us from
decisively indicating inter-device reliability of this version of the VO2 Master. Of note, interdevice reliability is of interest only if a team/lab/clinic is using more than one analyzer and/or
is looking to compare data to that of other teams/labs/clinics. Settings in which the same
analyzer is used to collect data should be more concerned with validity and test-retest reliability
of the analyzer. The use of different mouthpieces is a study limitation in that it could
theoretically change breathing patterns or physiologic load of activity. However, the heart rate
and RPE data suggest little difference in physiologic load, and breathing frequency and tidal
volume (data not shown but available upon request) were not different between analyzers.
Finally, while the VO2 Master version 1.2.1 has the ability to assess resting VO2, we did not
include resting measures in our study since data collection was nearly complete for the VO2
Master version 1.1.1 (which does not measure resting VO2) and Parvomedics by the time the
VO2 Master version 1.2.1 was released. Future research should validate resting VO2 and minute
ventilation data from the VO2 Master. Finally, as a major use of portable analyzers is
measurement in field settings, the VO2 Master should be further validated in a variety of
environmental (e.g., temperature, humidity, wind) conditions.
Conclusions: In conclusion, our study found acceptable convergent validity and test-retest
reliability of the VO2 Master Pro analyzer for assessment of exercise VO2 and minute ventilation,
compared to the Parvomedics analyzer. Validity and reliability measures of the VO2 Master
found in this study were comparable to those of other major portable metabolic analyzer brands
(e.g., COSMED, Oxycon, MetaMax) in past research. While further work is needed to confirm
these findings, our results suggest that the VO2 Master Pro is likewise a suitable option for those
looking to measure VO2 and minute ventilation during moderate- and vigorous-intensity
exercise in field settings.
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